Table 5 Relation between median IL-17, lines of treatment, duration of disease and hospital admission among IBD cases
From: Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity
IL-17 (pg/mL) | Test of significance | |
|---|---|---|
Treatment lines | ||
5- ASA | 60 (51–502) | KW = 0.679 |
Azathioprine + Steroid | 65 (21–210) | P = 0.712 |
Biological lines | 70 (25–260) | |
Duration of disease in years | ||
˂ 1 year | 55 (15–260) | KW = 0.886 |
1–5 years | 55.5 (14–502) | P = 0.642 |
5–10 years | 61.5(16–201) | |
˃ 10 years | 72 (14–160) | |
Hospital admission | ||
Yes | 73 (41–260) | Z = 3.15 |
No | 55 (14–502) | P = 0.002* |